A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Royalty Pharma PLC stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 108,546 shares of RPRX stock, worth $2.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
108,546
Previous 107,260 1.2%
Holding current value
$2.74 Million
Previous $2.83 Million 8.56%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.63 - $29.27 $32,960 - $37,641
1,286 Added 1.2%
108,546 $3.07 Million
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $102,230 - $116,400
-3,893 Reduced 3.5%
107,260 $2.83 Million
Q1 2024

May 15, 2024

BUY
$27.46 - $31.33 $3.05 Million - $3.48 Million
111,153 New
111,153 $3.13 Billion
Q3 2023

Aug 14, 2024

SELL
$26.26 - $31.38 $210,815 - $251,918
-8,028 Reduced 6.91%
108,152 $2.94 Billion
Q2 2023

Aug 14, 2024

SELL
$29.6 - $36.56 $2.28 Million - $2.81 Million
-76,935 Reduced 39.84%
116,180 $3.57 Billion
Q1 2023

Aug 14, 2024

BUY
$32.77 - $39.4 $6.33 Million - $7.61 Million
193,115 New
193,115 $6.96 Billion
Q4 2022

Aug 14, 2024

SELL
$39.17 - $44.04 $5.88 Million - $6.61 Million
-149,992 Closed
0 $0
Q3 2022

Aug 14, 2024

BUY
$39.88 - $44.65 $17,706 - $19,824
444 Added 0.3%
149,992 $6.03 Billion
Q2 2022

Aug 14, 2024

BUY
$37.53 - $44.22 $4.74 Million - $5.59 Million
126,358 Added 544.88%
149,548 $6.29 Billion
Q1 2022

Aug 14, 2024

SELL
$37.46 - $42.44 $3.15 Million - $3.57 Million
-84,070 Reduced 78.38%
23,190 $903 Million
Q3 2021

Aug 30, 2024

BUY
$36.14 - $42.24 $14,239 - $16,642
394 Added 30.19%
1,699 $61.3 Million
Q2 2021

Aug 30, 2024

SELL
$39.85 - $46.63 $4.22 Million - $4.94 Million
-105,955 Reduced 98.78%
1,305 $53.4 Million
Q4 2020

Aug 30, 2024

SELL
$36.12 - $50.05 $3.83 Million - $5.3 Million
-105,955 Reduced 98.78%
1,305 $65.3 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.